Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans

Govindarajan Rajagopalan, Yogish C. Kudva, Lieping Chen, Li Wen, Chella S. David

Research output: Contribution to journalArticle

Abstract

The major predisposing genetic component in type 1 diabetes (T1D) maps to the MHC locus in both mice and humans. To better understand the HLA class II association with disease pathogenesis, we bred mice expressing HLA-DQ8 and -DR3, either alone or in combination, to transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans. Spontaneous diabetes occurred only in RIP-B7-1 transgenic mice expressing transgenic HLA-DR3 or -DQ8 molecules and the incidence of diabetes was comparable between the two (∼30% in either sex up to 50 weeks of age). Presence of DR3 and DQ8 together only marginally elevated the overall incidence of spontaneous disease (38%). Non-specific activation of T cells by superantigen and provision of concomitant co-stimulation through 4-1BB (CD137) by an agonistic antibody did not accelerate the incidence of diabetes over a short period of time. Neither the antibody-mediated depletion of CD25+ T cells nor sublethal, whole-body irradiation of young, naive HLA transgenic mice expressing RIP-B7-1 resulted in diabetes. However, administration of only two doses of the β cell toxin streptozotocin (STZ; 40 mg/kg) induced autoimmune diabetes in 85% of mice within 7 weeks after STZ treatment only when B7-1 was expressed on the pancreatic β cells. This effect was HLA dependent as none of the STZ-treated RIP-B7-1 transgenic mice lacking HLA class II developed diabetes. In conclusion, this study confirmed the diabetogenic potential of HLA-DQ8 and established the role of HLA-DR3 in the pathogenesis of T1D.

Original languageEnglish (US)
Pages (from-to)1035-1044
Number of pages10
JournalInternational Immunology
Volume15
Issue number9
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

B7 Antigens
HLA-DR3 Antigen
Type 1 Diabetes Mellitus
Islets of Langerhans
Transgenic Mice
Incidence
T-Lymphocytes
Superantigens
Antibodies
Whole-Body Irradiation
Streptozocin
HLA-DQ8 antigen

Keywords

  • Autoimmunity
  • Diabetes
  • HLA-DQ8
  • HLA-DR3
  • Transgenic/knockout

ASJC Scopus subject areas

  • Immunology

Cite this

Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans. / Rajagopalan, Govindarajan; Kudva, Yogish C.; Chen, Lieping; Wen, Li; David, Chella S.

In: International Immunology, Vol. 15, No. 9, 01.09.2003, p. 1035-1044.

Research output: Contribution to journalArticle

Rajagopalan, Govindarajan ; Kudva, Yogish C. ; Chen, Lieping ; Wen, Li ; David, Chella S. / Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans. In: International Immunology. 2003 ; Vol. 15, No. 9. pp. 1035-1044.
@article{91d84f9339574671b843973822851747,
title = "Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans",
abstract = "The major predisposing genetic component in type 1 diabetes (T1D) maps to the MHC locus in both mice and humans. To better understand the HLA class II association with disease pathogenesis, we bred mice expressing HLA-DQ8 and -DR3, either alone or in combination, to transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans. Spontaneous diabetes occurred only in RIP-B7-1 transgenic mice expressing transgenic HLA-DR3 or -DQ8 molecules and the incidence of diabetes was comparable between the two (∼30{\%} in either sex up to 50 weeks of age). Presence of DR3 and DQ8 together only marginally elevated the overall incidence of spontaneous disease (38{\%}). Non-specific activation of T cells by superantigen and provision of concomitant co-stimulation through 4-1BB (CD137) by an agonistic antibody did not accelerate the incidence of diabetes over a short period of time. Neither the antibody-mediated depletion of CD25+ T cells nor sublethal, whole-body irradiation of young, naive HLA transgenic mice expressing RIP-B7-1 resulted in diabetes. However, administration of only two doses of the β cell toxin streptozotocin (STZ; 40 mg/kg) induced autoimmune diabetes in 85{\%} of mice within 7 weeks after STZ treatment only when B7-1 was expressed on the pancreatic β cells. This effect was HLA dependent as none of the STZ-treated RIP-B7-1 transgenic mice lacking HLA class II developed diabetes. In conclusion, this study confirmed the diabetogenic potential of HLA-DQ8 and established the role of HLA-DR3 in the pathogenesis of T1D.",
keywords = "Autoimmunity, Diabetes, HLA-DQ8, HLA-DR3, Transgenic/knockout",
author = "Govindarajan Rajagopalan and Kudva, {Yogish C.} and Lieping Chen and Li Wen and David, {Chella S.}",
year = "2003",
month = "9",
day = "1",
doi = "10.1093/intimm/dxg103",
language = "English (US)",
volume = "15",
pages = "1035--1044",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans

AU - Rajagopalan, Govindarajan

AU - Kudva, Yogish C.

AU - Chen, Lieping

AU - Wen, Li

AU - David, Chella S.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - The major predisposing genetic component in type 1 diabetes (T1D) maps to the MHC locus in both mice and humans. To better understand the HLA class II association with disease pathogenesis, we bred mice expressing HLA-DQ8 and -DR3, either alone or in combination, to transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans. Spontaneous diabetes occurred only in RIP-B7-1 transgenic mice expressing transgenic HLA-DR3 or -DQ8 molecules and the incidence of diabetes was comparable between the two (∼30% in either sex up to 50 weeks of age). Presence of DR3 and DQ8 together only marginally elevated the overall incidence of spontaneous disease (38%). Non-specific activation of T cells by superantigen and provision of concomitant co-stimulation through 4-1BB (CD137) by an agonistic antibody did not accelerate the incidence of diabetes over a short period of time. Neither the antibody-mediated depletion of CD25+ T cells nor sublethal, whole-body irradiation of young, naive HLA transgenic mice expressing RIP-B7-1 resulted in diabetes. However, administration of only two doses of the β cell toxin streptozotocin (STZ; 40 mg/kg) induced autoimmune diabetes in 85% of mice within 7 weeks after STZ treatment only when B7-1 was expressed on the pancreatic β cells. This effect was HLA dependent as none of the STZ-treated RIP-B7-1 transgenic mice lacking HLA class II developed diabetes. In conclusion, this study confirmed the diabetogenic potential of HLA-DQ8 and established the role of HLA-DR3 in the pathogenesis of T1D.

AB - The major predisposing genetic component in type 1 diabetes (T1D) maps to the MHC locus in both mice and humans. To better understand the HLA class II association with disease pathogenesis, we bred mice expressing HLA-DQ8 and -DR3, either alone or in combination, to transgenic mice expressing the co-stimulatory molecule B7-1 in the β cells of islets of Langerhans. Spontaneous diabetes occurred only in RIP-B7-1 transgenic mice expressing transgenic HLA-DR3 or -DQ8 molecules and the incidence of diabetes was comparable between the two (∼30% in either sex up to 50 weeks of age). Presence of DR3 and DQ8 together only marginally elevated the overall incidence of spontaneous disease (38%). Non-specific activation of T cells by superantigen and provision of concomitant co-stimulation through 4-1BB (CD137) by an agonistic antibody did not accelerate the incidence of diabetes over a short period of time. Neither the antibody-mediated depletion of CD25+ T cells nor sublethal, whole-body irradiation of young, naive HLA transgenic mice expressing RIP-B7-1 resulted in diabetes. However, administration of only two doses of the β cell toxin streptozotocin (STZ; 40 mg/kg) induced autoimmune diabetes in 85% of mice within 7 weeks after STZ treatment only when B7-1 was expressed on the pancreatic β cells. This effect was HLA dependent as none of the STZ-treated RIP-B7-1 transgenic mice lacking HLA class II developed diabetes. In conclusion, this study confirmed the diabetogenic potential of HLA-DQ8 and established the role of HLA-DR3 in the pathogenesis of T1D.

KW - Autoimmunity

KW - Diabetes

KW - HLA-DQ8

KW - HLA-DR3

KW - Transgenic/knockout

UR - http://www.scopus.com/inward/record.url?scp=0042353612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042353612&partnerID=8YFLogxK

U2 - 10.1093/intimm/dxg103

DO - 10.1093/intimm/dxg103

M3 - Article

C2 - 12917255

AN - SCOPUS:0042353612

VL - 15

SP - 1035

EP - 1044

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 9

ER -